recurrence

Apple CEO Steve Jobs may have only 6 weeks to live

Speculation surrounding Apple Inc.'s (NASDAQ:AAPL) Chief Executive Officer Steve Paul Jobs' health is rife with conjectures that the computer genius is terminally ill with only weeks to live.

steve-jobs-3g-iphone.jpg

Jobs is currently on his third medical leave to deal with health issues.

The Apple CEO announced in late January that "at my request, the board of directors has granted me a medical leave of absence so I can focus on my health".

Steve Jobs has been battling serious health issues over seven years.

In August 2004, Jobs underwent successful surgery to treat a rare form of pancreatic cancer, which laid him up until September of that year. He had also undergone a liver transplant in 2009.

The rumors doing the rounds are that he is once again stricken with the malignancy.

Alcohol intake increases the risk of breast cancer in early stage patients—study

Alcohol consumption elevates the risk of breast cancer recurrence in woman who were earlier diagnosed with the disease, reveals a novel study.

images.jpeg

"Our study increases the limited and mixed evidence base to date regarding the role of alcohol consumption and breast cancer prognosis; namely, that drinking moderate to heavy amounts of alcohol after a breast cancer diagnosis can possibly increase the risk of having a recurrence of breast cancer and dying from breast cancer," lead author Marilyn Kwan, PhD, a research scientist at Kaiser Permanente in Oakland, California, told Medscape Medical News said.

Gene test could detect cancer, reveals study

In a breakthrough discovery, scientists claim that detection of cancer tumors in blood could help doctors customize the treatment for individual patients, making it much simpler and cost-effective.

blood test.jpg

Researchers at Johns Hopkins University in Baltimore, America established that tests would scan ‘genetic fingerprints’ of the patients to spot early signs of cancer along with its recurrence.

Lead researcher, Victor E. Velculescu, MD, PhD, Johns Hopkins University, who presented the study at American Association for the Advancement of Science meeting, San Diego said, “This is a great tool towards made-to-measure cancer care.”

“This will be a step towards cancer becoming a manageable chronic disease rather than an acute terminal disease,” added Velculescu.

Syndicate content